MBBS (Hons), PhD (Cambridge), FRCS (Gen), FAMS
Specialty: Surgery ＆ Surgical Oncology
Sub-specialties: Head ＆ Neck, Thyroid, Skin ＆ Melanoma, Salivary Glands, Head ＆ Neck (including Melanoma)
Conditions Treated by this Doctor:
Head and Neck Cancer, Larynx Cancer, Melanoma, Nasopharyngeal Cancer (Nose Cancer), Oral Cancer, Salivary Gland Cancer, Skin Cancer, Thyroid Cancer.
Prof Gopal Iyer graduated top of his medical school class at NUS in 1998, with Honours. He subsequently went on to complete a PhD in molecular carcinogenesis at the University of Cambridge under Prof Carlos Caldas. Trained as a General surgeon at Singapore General Hospital he went on to two separate head and neck surgical fellowships at Sydney Head and Neck Cancer Institute at Royal Prince Alfred Hospital, Australia and Memorial Sloan-Kettering Cancer Centre (MSKCC), New York, USA. At the end of his fellowship at MSKCC, he was awarded the Michael Burt award for being the best fellow in the surgical division both in terms of operative skill and research output.
Currently, Prof Gopal Iyer works as a Head and Neck surgeon in National Cancer Centre Singapore and Singapore General Hospital. He is also Senior Consultant of the SingHealth Duke-NUS Head and Neck Centre. Prof Gopal Iyer has extensive experience in the surgical management of head and neck cancers, as well as surgery for benign diseases in the head and neck (including thyroid, salivary gland and skin lesions). He performs complex resections and reconstructions of cancers involving the oral cavity, oropharynx, larynx, hypopharynx, nasopharynx, paranasal sinuses and neck. He is involved in the robotic and endoscopic head and neck surgical program having performed a number of these procedures locally and mentored the first ever robotic thyroidectomy in Australia in Feb 2012.
1. Drugging the undruggable- targeting wild type EGFR with exosomal therapeutics National Medical Research Council Clinical Scientist Individual Research Grant (CIRG21jun-0035) for $1,494,200; Feb 2022 to 31 Jan 2025) – currently ongoing 2. Precision oncology approach to identification and expansion of tumour-targeting cytotoxic T-lymphocytes in head and neck squamous cell cancer. National Medical Research Council Clinician Scientist Award – Senior Investigator Grant (MOH-000325) for $1,748,900; Jan 2020 to Dec 2024) – currently ongoing 3. Precision immunotherapy for gastric, and head and neck cancer targeting the MARK3 splice variant antigen. National Health Innovation Centre Singapore I2D grant (NHIC-I2D-1912237) for $250,000; Aug 2020- Jul 2021) as CO-I
4. Next-generation lung cancer clinical trials. National Medical Research Council Large Collaborative grant for $1,130,000; May 2018 – Apr 2023 as theme PI 5. The Role of Tumor Heterogeneity in Lymph Node Metastasis in Oral Squamous Cell Carcinoma (OSCC): A Precision Medicine Approach (NMRC/CSA-INV/0011/2016 for $1,200,000; Nov 2016 - Oct 2019)
Subscribe to our mailing list to get the updates to your email inbox...
30 Hospital Boulevard, 168583 +65 6436 8000